Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
100 Billion Reasons to Like This Dominant Healthcare Stock
11:00am, Monday, 06'th Jun 2022 The Motley Fool
This mega-cap stock will become the first in the pharmaceutical industry to reach a major sales milestone.
Can the Best-Selling Drugs of 2021 Repeat Their Performance?
09:43am, Sunday, 05'th Jun 2022 The Motley Fool
These were the industry's bestsellers last year, but how long can they stay on top?
In boost for parents, Biden administration says COVID vaccine for kids under 5 could start June 21, and Prince Andrew misses Jubilee event after testing positive
03:47pm, Friday, 03'rd Jun 2022 MarketWatch
Children under five years old could begin to receive vaccinations against COVID-19 as early as June 21, a top Biden administration official said Thursday, in a boost for parents anxious for very young
Is This Dividend Stock a Buy for Income Investors?
02:15pm, Friday, 03'rd Jun 2022 The Motley Fool
There has been a significant rotation from growth stocks into value stocks this year.
Pfizer (PFE) Leads as US Plans Kids' COVID Vaccination in June
01:57pm, Friday, 03'rd Jun 2022 Zacks Investment Research
The FDA accepts the EUA request from Pfizer (PFE) for its COVID-19 vaccine for use in kids below 5 years of age. The U.S. government plans to start vaccinating these kids in June, following an FDA pan
Why Pfizer Needs a High-Growth Pipeline
11:54am, Friday, 03'rd Jun 2022 The Motley Fool
The company moves to build a solid lineup to replace COVID-19 revenue that just can't last.
Pfizer and BioNTech seek FDA authorization for 3-dose vaccine for children between 6 months and 5 years old, and WHO warns that fewer tests mean fewer cases detected
10:27am, Friday, 03'rd Jun 2022 MarketWatch
Pfizer and BioNTech have asked the U.S. Food and Drug Administration to authorize their three-dose vaccine for children aged six months to five years, in a move that could add roughly 19 million young
Why Moderna and Pfizer Lagged the Market Today
10:05pm, Thursday, 02'nd Jun 2022 The Motley Fool
The amendment to a European Union supply agreement is spooking investors.
Pfizer (PFE) Gains But Lags Market: What You Should Know
09:45pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
Pfizer (PFE) closed at $52.68 in the latest trading session, marking a +0.59% move from the prior day.
Dow, S&P 500, Nasdaq score best day in nearly a week despite Microsoft warning on dollar stocks
08:31pm, Thursday, 02'nd Jun 2022 MarketWatch
U.S. stocks close near session highs Thursday, shrug off hawkish Fed tones on rates and Microsoft cutting guidance for the fiscal fourth quarter, citing a strong U.S. dollar.
Pfizer and BioNTech seek FDA authorization for 3-dose vaccine for children between 6 months and 5 years old, and WHO warns that fewer tests mean fewer cases detected
07:49pm, Thursday, 02'nd Jun 2022 MarketWatch
Pfizer and BioNTech have asked the U.S. Food and Drug Administration to authorize their three-dose vaccine for children aged six months to five years, in a move that could add roughly 19 million young
Pfizer (PFE) Up 5.5% Since Last Earnings Report: Can It Continue?
03:31pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Does This News From Switzerland Mean Trouble for Moderna?
02:00pm, Thursday, 02'nd Jun 2022 The Motley Fool
It has to do with vaccine demand.
GSK Receives Regulatory Nod for Consumer Healthcare Demerger
01:17pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
GSK progresses with the separation of its Consumer Healthcare business from biopharmaceuticals into a separate public company, Haleon, as it gets regulatory approval from the FCA.
Stock Market Plunge: 2 Stocks to Avoid Right Now
12:45pm, Thursday, 02'nd Jun 2022 The Motley Fool
Prudent investors should look elsewhere.
